(1)
Blauvelt, A.; Alonso-Llamazares, J.; Bhatia, N.; Draelos, Z.; DuBois, J.; Forman, S.; Gooderham, M.; Guenthner, S.; Hebert, A.; Lain, E.; Moore, A.; Papp, K.; Stein Gold, L.; Zirwas, M.; Kato, S.; Snyder, S.; Krupa, D.; Burnett, P.; Berk, D.; Chu, D. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial. J of Skin 2023, 7, s196.